Abstract
Objective
The development of a new tracer based on the cyclic sulfonamides (sultams) was investigated.
Methods
3-(Methoxy-phenyl-methyl)-1,6-dimethyl-1H benzo[c][1,2] thiazine 2,2-dioxide (benzo-δ-sultam) was synthesized and characterized by elemental analysis, FT-IR spectroscopy and single crystal X-ray structure determination. The prepared cyclic sulfonamide was labeled with non-commercial 62Zn radioisotope for fast in vivo targeting and Coincidence imaging purposes (radiochemical purity 97 % ITLC, 96 % HPLC, specific activity 20–23 GBq/mmol). In vivo biodistribution of the final complex was investigated in Sprague Dawley® rats bearing fibro sarcoma tumor after 2, 4 and 8 h post injection and compared with free Zn+2 cation.
Results
Using instant paper chromatography method, the physicochemical properties of labeled compounds were found sufficiently stable in organic phases, e.g. a human serum, to be reliably used in bioapplications.
Conclusions
The complex exhibited a rapid as well as high tumor uptake (tumor to blood ratio 4.38 and tumor to muscle ratio 9.63) resulting in an efficient tumor targeting agent.
Similar content being viewed by others
References
Blower PJ, Lewis JS, Zweit J. Copper radionuclides and radiopharmaceuticals in nuclear medicine. Nucl Med Biol. 1996;23:957.
Qaim SM. Use of cyclotrons in medicine. Radiat Phys Chem. 2004;71:917.
Piel H, Qai SM, Stöcklin G. Excitation functions of (p, xn)-reactions on natNi and highly enriched 62Ni: possibility of production of medically important radioisotope 62Cu at a small cyclotron. Radiochim Acta. 1992;57:1–5.
Szelecsenyi F, Suzuki K, Kovacs Z, Takei M, Okada K. Production possibility of 60, 61, 62 Cu radioisotopes by alpha induced reactions on cobalt for PET studies. Nucl Instrum Methods B. 2002;187:153–63.
Fujibayashi Y, Taniuchi H, Yonekura Y, Ohtani H, Konishi J, Yokoyama A. Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential. J Nucl Med. 1997;38:1155–60.
Takahashi N, Fujibayashi Y, Yonekura Y. Evaluation of 62Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer. Ann Nucl Med. 2000;14:323–8.
Jalilian AR, Fateh B, Ghergherehchi M, Karimian A. Development of [62Zn] bleomycin as a possible PET tracer. Nukleonika. 2005;50:143–8.
Fujibayashi Y, Saji H, Yomoda I, Kawai K, Horiuchi K, Adachi H, Torizuka K, Yokoyama A. 62Zn-EDDA: a radiopharmaceutical for pancreatic functional diagnosis. Int J Nucl Med Biol. 1986;12:439–46.
Aghanejad A, Jalilian AR, Fazaeli Y, Beiki D, Fateh B, Ali Khalaj. Radiosynthesis and biodistribution studies of [62Zn/62Cu]–plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging. J Radioanal Nucl Chem. 2014;299:1635–44.
Tamura M, Matsui H, Hirohara S, Kakiuchi K, Tanihara M, et al. Selective accumulation of [62Zn]-labeled glycoconjugated porphyrins as multi-functional positron emission tomography tracers in cancer cells. Bioorg Med Chem. 2014;22:2563–70.
Fujibayashi Y, Matsumoto K, Yonekura Y, Konishi J, Yokoyama A. A new zinc-62/copper-62 generator as a copper-62 source for PET radiopharmaceuticals. J Nucl Med. 1989;30(11):1838–42.
Lacy JL, Chien SC, Lim JK, Mathias CJ, Green MA. Modular automated Zn-62/Cu-62 PET radiopharmaceutical generator. J Nucl Med. 1995;36:49.
Matsumoto K, Fujibayashi Y, Yonekura Y. Application of the new zinc-62/copper-62 generator: An effective labeling method for Cu-PTSM. Nucl Med Biol. 1992;19(1):39–44.
Robinson JGD, Zielinski FW, Lee AW. The Zinc-62/Copper-62 generator: a convenient source of Copper-62 for radiopharmaceuticals. Appl Radiat Isot. 1980;31(2):111–6.
Smits RA, Adami M, Istyastono EP, Zuiderveld OP, van Dam CME, de Kanter FJJ, Jongejan A, Coruzzi G, Leurs R, de Esch IJP. Synthesis and QSAR of quinazoline sulfonamides as highly potent human histamine H4 receptor inverse agonists. J Med Chem. 2010;53(6):2390–400.
Kim CY, Whittington DA, Chang JS, Liao J, May JA, Christianson DW. Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IV. J Med Chem. 2002;45:888–93.
Inagaki M, Tsuri T, Jyoyama H, Ono T, Yamada K, Kobayashi M, Hori Y, Arimura A, Yasui K, Ohno K, Kakudo S, Koizumi K, Suzuki R, Kato M, Kawai S, Matsumoto S. Novel antiarthritic agents with 1,2-isothiazolidine-1,1-dioxide (γ-sultam) skeleton: cytokine suppressive dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase. J Med Chem. 2000;43(10):2040–8.
Cherney RJ, Dayton RM, Meyer T, Hardman KD, Liu RQ, Covington MB, Qian M, Wasserman ZR, Christ DD, Trzaskos JM, Newton RC, Decicco CP. Sultam hydroxamates as novel matrix metalloproteinase inhibitors. J Med Chem. 2004;47(12):2981–3.
Ali A, Reddy GSKK, Cao H, Anjum SG, Nalam MNL, Schiffer CA, Rana TM. Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-Aryl-oxazolidinone-5-carboxamides as novel P2 ligands. J Med Chem. 2006;49(25):7342–56.
McKeown SC, Hall A, Blunt R, Brown SH, Chessell IP, Chowdhury A, Giblin GMP, Healy MP, Johnson MR, Lorthioir O, Michel AD, Naylor A, Lewell X, Roman S, Watson SP, Winchester WJ, Wilson RJ. Identification of novel glycine sulfonamide antagonists for the EP1 receptor. Bioorg Med Chem Lett. 2007;17(6):1750–4.
Council Biological. Guidelines on the use of living animals in scientific investigations. 2nd ed. London: Biological Council; 1987.
Weisberg AM. Gold plating. 9th ed. USA: ASM International; 1990. p. 247.
The crystallographic information file has been deposited with the Cambridge Data Centre, CCDC 974372.
X-STEP32 Version 1.07b, Crystallographic Package; Stoe & Cie GmbH: Darmstadt, Germany, 2000.
Aboudzadeh M, Fazaeli Y, Khodaverdi H, Afarideh H. Production, nano-purification, radiolabeling and biodistribution study of [140Nd] 5,10,15,20-tetraphenylporphyrin complex as a possible imaging agent. J Radioanal Nucl Chem. 2013;295:105.
Fukumura T, Okada K, Suzuki H, Nakao R, Mukai K, Szelecsenyi F, Kovacs Z, Suzuki K. An improved 62Zn/62Cu generator based on a cation exchanger and its fully remote-controlled preparation for clinical use. Nucl Med Biol. 2006;33(6):821–7.
Fazaeli Y, Amini MM, Najafi E, Mohajerani E, Janghouri M, Jalilian A, Ng SW. Synthesis and characterization of 8-hydroxyquinoline complexes of tin (IV) and their application in organic light emitting diode. J Fluoresc. 2012;22(5):1263–70.
Reference charged particle cross-section database for medical radioisotope production, Diagnostic radio isotopes and monitor reactions IAEA-TECDOC-1211, IAEA, Vienna, Austria, 2001.
Conflict of interest
The authors report no conflicts of interest in this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ghandi, M., Feizi, S., Ziaie, F. et al. Synthesis, characterization and in vivo evaluation of [62Zn]–benzo-δ-sultam complex as a possible pet imaging agent. Ann Nucl Med 28, 880–890 (2014). https://doi.org/10.1007/s12149-014-0885-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-014-0885-y